Most neonatal herpes infections are the result of undiagnosed, new-onset herpes simplex virus (HSV) infection in the mother. How can mother-to-child transmission be prevented to improve outcomes?

Introduction. HSV and varicella zoster virus (VZV) are large, dsDNA viruses of the Herpesviridae family. They induce disorders with a wide range of clinical manifestations, including mucocutaneous ...

The Herpes simplex virus, transmitted primarily by saliva, was firstly isolated in 1939 in children afflicted with herpetic gingivostomatitis. Fever, irritability, pain when swallowing, regional ...

Design We performed a meta-analysis of observational studies to assess the association between statin use and the risk of herpes zoster infection. We searched PubMed, Embase, Web of Science and ...

It leverages HSV color space masking, trackbars for dynamic range adjustment, and real-time video processing to replace specific color ranges with a background frame, creating a magical invisibility ...

Objective To assess incidence and burden of neonatal herpes simplex virus (HSV) infections and to explore possible transmission routes. Methods A 2-year prospective nationwide surveillance study ...

Herpes simplex virus-1 (HSV-1) is a pathogen that may cause severe encephalitis in humans. In this study, we aimed to investigate the role of interleukin-4 (IL-4) in a model of HSV-1 brain infection.

Researchers at the University of Georgia (UGA) have developed a promising new molecule that could lead to better treatments for viruses like shingles, chickenpox, and herpes. The team, led by ...

Cold sores develop in response to infection with the herpes simplex virus (HSV), but early treatment with topical applications — such as creams, patches, and balms — may help manage them. Cold ...

Infections caused by herpes simplex virus type 1 (HSV-1) can lead to HSV-1 encephalitis—a rare but deadly condition that inflames the brain. Despite decades of research, treatment options for ...

A cousin of herpes might just help us fight cancer. Scientists have engineered a protein derived from a herpesvirus in monkeys that could enhance the immune system’s potency against cancer.